Federal Circuit: Proposed Generic Drug Does Not Meet Patent Limitations
WASHINGTON, D.C. — A Florida federal judge erred in concluding that an abbreviated new drug application (ANDA) satisfies various Markush group requirements set forth in claim 1(b) of a drug composition...To view the full article, register now.
Already a subscriber? Click here to view full article